Li Rui guessed why Michael asked for a price all over the place.

Perhaps because the research of psi-7977 was progressing smoothly, Michael saw the dawn of success, so he was unwilling to sell the profit rights and company equity at a low price.

But from another perspective, it can also be confirmed that pharmaset is indeed exhausted from ammunition and food, otherwise they will succeed if they hold on for another half a year, and they will be sold at a sky-high price of 11 billion in another year. Why is it now

Sell ​​at a low price?

Li Rui didn't know how Pharmasset got through the difficulties in his previous life, but it is certain that this opportunity must not be missed.

Michael on the screen fell into a long exam, and Li Rui pretended to be relaxed and started chatting with Fu Shande and Yu Na.

[Li Rui]: How is Smith Mining Company progressing?

【Yu Na】: Everything went very smoothly.

[Li Rui]: It's a good job. I will return to China in more than ten days. Then I will help you with light skills.

[Yu Na]: Then I want to have a big meal.

They chatted easily, but Michael was whispering something to several people outside the camera from time to time.

Finally, Michael spoke again: Mr. Li Rui, I have to admit that sofosbuvir has no chance to conduct clinical experiments, but our research ideas are very correct, and we firmly believe that sofosbuvir

It will be an epoch-making drug! We understand your control over risks, so we are willing to make a slight concession based on the previous quotation.

[Li Rui]: What is the extent of the concession?

[Michael middot; Sofia]: 50% of the income rights of Sofosbuvir, 600 million magnesium. 40% of the shares of pharmaset, 150 million magnesium.

Li Rui shook his head: This is not a sincere price. If your company cannot make greater concessions, we don’t have to continue to negotiate.

Michael said helplessly: We think this is a very sincere price!

Li Rui said: Dr. Michael, if the news I found out is correct, two years ago you wanted to transfer the R&D rights of Sofosbuvir to Gilead, and the offer was only 300 million magnesium! Two years have passed, your research and development

There is no more progress, but I want to sell 50% of sofosbuvir for 600 million magnesium. Do you think of me as a sucker?

Yu Na quickly translated the meaning of the three words "super" and "super".

After hearing the translation, Michael hurriedly said: No, no, no, I definitely don’t have that meaning. What you said did happen two years ago, but at that time, Sofosbuvi encountered difficulties in research and development and had problems in research direction, so we thought.

Transfer. Sofosbwe's prospects are very good now. In your words, one time and another

Li Rui smiled: Is there no difficulties in your company now? If it is really so promising, why not continue to develop by yourself? Why sell it to me?

Michael was speechless.

At this time, Fu Shande spoke at the right time: Actually, one of you wants to buy and the other wants to sell. The main problem now lies in the price. As an intermediary, I hope you can give the psychological price you can accept openly. If the difference is not much, we will continue to talk.

If there is too much difference, I think that's all today.

Fu Shande came up with a bad idea.

During formal negotiations, how can you reveal your trump card?

But this is not a formal negotiation, and there is already a slightest stance to be a breakdown, so bad ideas may not be a way.

Li Rui also secretly applauded, thanking Fu Shande for giving him a step.

Pharmasset and Sofobwe, Li Rui is determined to win, but he cannot show it too strongly, so as not to waste money.

This is not to buy Zhang Haixin’s copyright. If you spend a few million more, you will be a friend. As long as you give up, you will have to take out hundreds of millions of magnesium in real money!

Li Rui smiled: Dr. Michael, what do you think?

Michael was obviously a little worried about the price differences, and hesitated for a moment and said: Yes!

The two of them found a piece of paper and wrote down the price they thought was appropriate.

Fu Shandedao: I count three, two, one, please put the price in front of the camera.

Three, two, one, please.

Both of them raised the price at the same time.

Li Rui wrote: 300 million magnesium yuan and 100 million magnesium yuan.

Michael wrote: 350 million magnesium and 100 million magnesium.

Wow! Fu Shande showed a look of surprise. We don’t have much difference, right?

Michael made a huge concession, Li Rui also raised his offer slightly, and the firmness of the psychological bottom line between both sides was also clear.

Pharmasset really can't hold on anymore and can't let any investor go.

Li Rui also breathed a sigh of relief and won the bet.

If the disagreement is really too big, Michael will give up on his investment, he will really be troubled.

The gap of only 50 million magnesium was much easier on both sides and negotiations continued.

In the end, Li Rui made a step back and accepted Michael's price.

However, when discussing the issue of fund payment, the two sides had some debate.

Li Rui hopes to pay a 20% deposit in the first place and the remaining funds will be paid in installments within one year.

Michael hopes to get the first version of more than 100 million magnesium, and all funds will be available within half a year.

In fact, no matter which investment method is, it is very beneficial to Li Rui.

For as long as half a year and as short as a few months, there will be a major breakthrough in the development of sofosbuvir.

After learning about the results of the clinical trial of sofosbuvir, Gilead could not even wait for the end of all clinical trials. When sofosbuvir is still conducting the third phase of clinical trial and there is still a risk of being unable to go public, he will take out the market value.

One-third of the acquisition of Pharmasset and Sofobwe can be said to be a big bet, and it also shows from another perspective how great the potential of Sofobwe is.

Now 40% of the equity of pharmaset and 50% of the income rights of Sofosbuvi are in Li Rui's hands. Just a simple calculation can be found that the investment yield is more than ten times!

If Li Rui refuses to transfer Sofebwe's earnings rights and just sells the equity of pharmaset to Gilead, there is still a chance to share the profits of more than 30 billion magnesium in the next few years!

If you make enough money and make quick enough, Li Rui will no longer be petty about payment methods.

He made a relatively large concession, paying 100 million magnesium for the first time, paying 100 million magnesium for the second period within three months, paying 100 million magnesium for the third period and 150 million magnesium for the fourth period.

Payment in the sixth and eighth months.

Li Rui calculated that Gilead would come to you about before the third period of payment. So when the 250 million magnesium next time will be paid, there is actually no need to consider when the 250 million magnesium will be paid.

Two hundred million magnesium in three months.
Chapter completed!